Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-25T10:10:56.033Z Has data issue: false hasContentIssue false

Chapter 28 - Polycystic ovary syndrome

from Section V - Reproductive endocrinology and infertility

Published online by Cambridge University Press:  05 May 2016

Martin Olsen
Affiliation:
East Tennessee State University
Botros Rizk
Affiliation:
University of South Alabama
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Office Care of Women , pp. 311 - 321
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Stein, IF, Leventhal, ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181.CrossRefGoogle Scholar
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 Jan;81(1):1925.CrossRefGoogle Scholar
Balen, AH, Laven, JS, Tan, SL, Dewailly, D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003 Nov–Dec;9(6):505–14.CrossRefGoogle ScholarPubMed
Azziz, R, et al. for the Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006 Nov;91(11):4237–45.CrossRefGoogle ScholarPubMed
Knochenhauer ES1, Key, TJ, Kahsar-Miller, M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998 Sep;83(9):3078–82.Google Scholar
Li, R, Zhang, Q, Yang, D, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod 2013 Sep;28(9):2562–9.CrossRefGoogle Scholar
Ezeh, U, Yildiz, BO, Azziz, R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metabol 2013 Jun;98(6):E108896.CrossRefGoogle ScholarPubMed
Okoroh, EM, Hooper, WC, Atrash, HK, et al. Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003–2008. Am J Obstet Gynecol 2012 Oct;207(4):299.e17.CrossRefGoogle ScholarPubMed
Speroff, L, Fritz, MA. Clinical Gynecologic Endocrinology and Infertility, 7th edition. Philadelphia: Lippincott Williams & Wilkins, 2005; chapter 6, pp 187231.Google Scholar
Speroff, L, Fritz, MA. Clinical Gynecologic Endocrinology and Infertility, 7th edition. Philadelphia: Lippincott Williams & Wilkins, 2005; chapter 12, pp 465–98.Google Scholar
Nestler, JE, Powers, LP, Matt, DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991 Jan;72(1):83–9.CrossRefGoogle ScholarPubMed
Dunaif, A, Green, G, Futterweit, W, Dobrjansky, A. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1990 Mar;70(3):699704.CrossRefGoogle ScholarPubMed
ACOG. Practice Bulletin 108: polycystic ovary syndrome. October 2009.Google Scholar
Quinn, M, Shinkai, K, Pasch, L, et al. Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features. Fertility Steril. 2014 Apr;101(4):1129–34.CrossRefGoogle ScholarPubMed
Grundy, SM, Cleeman, JI, Daniels, SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 Oct 25;112(17):2735–52.Google ScholarPubMed
Ehrmann, DA, Liljenquist, DR, Kasza, K, et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006 Jan;91(1):4853.CrossRefGoogle ScholarPubMed
Karaca, Z, Acmaz, B, Acmaz, G, et al. Routine screening for Cushing’s syndrome is not required in patients presenting with hirsutism. Eur J Endocrinol 2013 Mar;168(3):379–84.CrossRefGoogle Scholar
Yildiz, BO. Assessment, diagnosis and treatment of a patient with hirsutism. Nat Clin Pract Endoc 2008;4:294300.CrossRefGoogle ScholarPubMed
Wang, S, Alvero, R. Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome. [Review] Semin Reprod Med 2013 Sep;31(5):365–9.Google ScholarPubMed
Clayton, RN, Ogden, V, Hodgkinson, J, et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol 1992 Aug;37(2):127–34.CrossRefGoogle ScholarPubMed
Robinson, S, Rodin, DA, Deacon, A, et al. Which hormone tests for the diagnosis of polycystic ovary syndrome? Br J Obstet Gynaecol 1992 Mar;99(3):232–8.CrossRefGoogle ScholarPubMed
Morgante, G, Musacchio, MC, Orvieto, R, et al. Alterations in thyroid function among the different polycystic ovary syndrome phenotypes. Gynecol Endocrinol 2013 Nov;29(11):967–9.CrossRefGoogle ScholarPubMed
Eilertsen, TB, Vanky, E, Carlsen, SM. Anti-mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod 2012 Aug;27(8):2494–502.CrossRefGoogle ScholarPubMed
Celik, C, Tasdemir, N, Abali, R, et al. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study. Fertil Steril 2014 Apr;101(4):1123–8.CrossRefGoogle ScholarPubMed
Legro, RS, Kunselman, AR, Dodson, WC, Dunaif, A, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999 Jan;84(1):165–9.Google ScholarPubMed
Shi, Y, Cui, Y, Sun, X, et al. Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors. Eur J Obstet Gynecol Reprod Biol 2014 Feb;173:6670.CrossRefGoogle ScholarPubMed
Legro, RS, Kunselman, AR, Dunaif, A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 2001 Dec 1;111(8):607–13.CrossRefGoogle ScholarPubMed
Mani, H, Levy, MJ, Davies, MJ, et al. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin Endocrinol 2013 Jun;78(6):926–34.CrossRefGoogle ScholarPubMed
Guzick, DS, Talbott, EO, Sutton-Tyrrell, K, et al. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol 1996 Apr;174(4):1224–9.CrossRefGoogle ScholarPubMed
Setji, TL, Holland, ND, Sanders, LL, et al. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006 May;91(5):1741–7.CrossRefGoogle ScholarPubMed
Sahingoz, M, Uguz, F, Gezginc, K, Korucu, DG. Axis I and Axis II diagnoses in women with PCOS. Gen Hospit Psychiat 2013 Sep–Oct;35(5):508–11.Google ScholarPubMed
Milsom, SR, Nair, SM, Ogilvie, CM, et al. Polycystic ovary syndrome and depression in New Zealand adolescents. J Pediat Adolesc Gynecol 2013 Jun;26(3):142–7.CrossRefGoogle ScholarPubMed
Boomsma, CM, Eijkemans, MJ, Hughes, EG, et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006 Nov–Dec;12(6):673–83.CrossRefGoogle ScholarPubMed
Rai, R, Backos, M, Rushworth, F, Regan, L. Polycystic ovaries and recurrent miscarriage – a reappraisal. Hum Reprod 2000;15(3):612–15.CrossRefGoogle ScholarPubMed
Grigorescu, V, Zhang, Y, Kissin, DM, et al. Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction. Fertil Steril 2014 Apr;101(4):1019–25.CrossRefGoogle ScholarPubMed
Knowler, WC, et al. for the Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 Feb 7;346(6):393403.Google ScholarPubMed
Panidis, D, Tziomalos, K, Macut, D, et al. Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome. Gynecol Endocrinol 2013 Oct;29(10):926–30.CrossRefGoogle ScholarPubMed
Vessey, M, Painter, R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968–2004. Br J Cancer 2006;95:385–89.CrossRefGoogle Scholar
Verit, FF. The prevalence of metabolic syndrome in clomiphene citrate resistant polycystic ovary syndrome. Gynecol Endocrinol 2012 May;28(5):365–9.CrossRefGoogle ScholarPubMed
Creanga, AA, Bradly, HM, McCormick, C, Witkop, CT. Use of metformin in polycystic ovary syndrome. Obstet Gynecol 2008;111(4): 959–68.CrossRefGoogle ScholarPubMed
Mathur, R, Alexander, CJ, Yano, J, et al. Use of metformin in polycystic ovary syndrome. Am Obstet Gynecol 2008 Dec;199(6): 596609.CrossRefGoogle ScholarPubMed
Nestler, JE, Jakubowicz, DJ, Evans, WS, Pasquali, R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. New Engl J Med 1998 Jun 25;338(26):1876–80.CrossRefGoogle ScholarPubMed
Velazquez, E, Acosta, A, Mendoza, SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 1997 Sep;90(3):392–5.Google ScholarPubMed
Marshall, JC, Dunaif, A. Should all women with PCOS be treated for insulin resistance? Fertil Steril 2012 Jan;97(1):1822.CrossRefGoogle ScholarPubMed
Palomba, S, Falbo, A, Zullo, F, Orio, F. Evidence based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 2013 July;30(1):150.CrossRefGoogle Scholar
Swiglo, BA, Cosma, M, Flynn, DN, et al. Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab 2008 Apr;93(4):1153–60.CrossRefGoogle ScholarPubMed
Pasquali, R, Gambineri, A. Glucose intolerance states in women with the polycystic ovary syndrome. [Review] J Endocrinol Invest 2013 Sep;36(8):648–53.Google ScholarPubMed
Lerchbaum, E, Schwetz, V, Giuliani, A, Obermayer-Pietsch, B. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method. Hum Reprod 2013 Sep;28(9):2537–44.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×